"seedTrialID","seedTrialTemplate","clinicalTrialsDotGovXmlRequired","leadOrgTrialID","clinicalTrialsDotGovTrialID","otherTrialID","title","phase","pilot","accrualDiseaseTerminology","primaryPurpose","primaryPurposeOtherDescription","interventionalDesign","interventionalDesign_secondaryPurpose","interventionalDesign_secondaryPurposeOtherDescription","leadOrganization","leadOrganization_existingOrganization","leadOrganization_existingOrganization_poID","pi","pi_existingPerson","pi_existingPerson_poID","sponsor","sponsor_existingOrganization","sponsor_existingOrganization_poID","responsibleParty","responsibleParty_type","responsibleParty_investigator","responsibleParty_investigator_existingPerson","responsibleParty_investigator_existingPerson_poID","responsibleParty_investigatorTitle","summary4FundingSponsor","summary4FundingSponsor_existingOrganization","summary4FundingSponsor_existingOrganization_poID","programCode","fundedByNciGrant","grant","grant_fundingMechanism","grant_nihInstitutionCode","grant_serialNumber","grant_nciDivisionProgramCode","grant_fundingPercentage","trialStatus","whyStopped","trialStatusDate","trialStartDate","trialStartDate_Actual","trialStartDate_Anticipated","primaryCompletionDate","primaryCompletionDate_Actual","primaryCompletionDate_Anticipated","completionDate","completionDate_Actual","completionDate_Anticipated","ind","ind_number","ind_grantor","ind_holderType","ind_nihInstitution","ind_expandedAccess","ind_expandedAccessType","ind_exempt","ide","ide_number","ide_grantor","ide_holderType","ide_nciDivisionProgramCode","ide_expandedAccess","ide_expandedAccessType","ide_exempt","regulatoryInformation","regulatoryInformation_country","regulatoryInformation_authorityName","regulatoryInformation_fdaRegulated","regulatoryInformation_section801","regulatoryInformation_delayedPosting","regulatoryInformation_dataMonitoringCommitteeAppointed","regulatoryInformation","protocolDocument","protocolDocument_filename","irbApprovalDocument","irbApprovalDocument_filename","participatingSitesDocument","participatingSitesDocument_filename","informedConsentDocument","informedConsentDocument_filename","otherDocument","otherDocument_filename","category","trialOwner"
"ST20182602A","complete","true","UPCC 75605092 seed data","NCT91914292",818280292,"A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy II","I","false","ICD10","Other","Determine maximum tolerated dose (MTD) of brentuximab vedotin",,"Other","Secondary Other Description",,,181802,,,5000,,,181802,,"Sponsor-Investigator",,,5000,"CEO &amp; Chairman",,,181802,"PG00001","false",,"B09","AA",111111,"CCR",100,"In Review",,2014-07-15,,2014-07-15,"X",,"X",2019-07-15,,"X",2019-07-15,,111111,"CDER","NIH","NEI","true","Available","true",,222222,"CDRH","NCI","CCR","true","Available","true",,"USA","Federal Government","true","true","true","true",,"dGVzdA==","protocol.pdf","dGVzdA==","irb.pdf","dGVzdA==","sites.pdf","dGVzdA==","consent.pdf","dGVzdA==","other.pdf","Externally Peer-Reviewed","qatest@nih.gov"
